Detalles de la búsqueda
1.
Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease.
BMC Med
; 18(1): 362, 2020 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33239013
2.
Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study.
Lancet Gastroenterol Hepatol
; 8(5): 446-457, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36898393
3.
A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease.
Front Immunol
; 12: 661622, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34093551
4.
Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease.
Aliment Pharmacol Ther
; 51(2): 244-252, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31769533
5.
Use of an exposure-response model to aid early drug development of an oral sphingosine 1-phosphate receptor modulator.
J Clin Pharmacol
; 49(1): 50-62, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18948412
6.
Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease.
Aliment Pharmacol Ther
; 50(5): 547-555, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31407810
7.
Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease.
Aliment Pharmacol Ther
; 50(8): 901-910, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31483515
8.
A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain.
Clin Ther
; 29(3): 399-412, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17577461
9.
Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa.
Clin Pharmacokinet
; 55(6): 641-55, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26620048
10.
Editorial: a non-dietary treatment for coeliac disease-two steps forward, one step back? Authors' reply.
Aliment Pharmacol Ther
; 50(8): 956-957, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31591779
11.
Safety and efficacy of colesevelam HCl in the treatment of elderly patients.
Drugs Aging
; 31(6): 461-70, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24777691
12.
Pharmacological modulation of peripheral T and B lymphocytes by a selective sphingosine 1-phosphate receptor-1 modulator.
J Clin Pharmacol
; 52(7): 996-1006, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21566200
13.
Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients.
J Neuroimmunol
; 246(1-2): 100-7, 2012 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22465063
14.
Diabetic macular edema: correlations with available diabetes therapies--evidence across a qualitative review of published literature from MEDLINE and EMBASE.
Drug Saf
; 33(8): 643-52, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20635822
15.
A 26-week, placebo- and pioglitazone-controlled, dose-ranging study of rivoglitazone, a novel thiazolidinedione for the treatment of type 2 diabetes.
Curr Med Res Opin
; 26(6): 1321-31, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20370378
16.
Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
Arch Intern Med
; 168(18): 1975-83, 2008 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-18852398
17.
Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
Diabetes Care
; 31(8): 1479-84, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18458145
18.
Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Arch Intern Med
; 168(14): 1531-40, 2008 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-18663165
19.
A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa.
Dig Dis Sci
; 52(2): 442-50, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17216336
Resultados
1 -
19
de 19
1
Próxima >
>>